Current insights into the pathogenesis of Graves' orbitopathy.
about
The role of thyrotrophin receptor antibody assays in graves' diseaseRituximab for thyroid-associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyEstablishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implicationsMutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathyThe role of oxidative stress on the pathogenesis of graves' disease.Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated OphthalmopathyMesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathyElevated percentage of HLA-DR⁺ and ICAM-1⁺ conjunctival epithelial cells in active Graves' orbitopathy.Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.Targeting the thyrotropin receptor in thyroid disease.Management of strabismus in thyroid eye disease.PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.[Update on endocrine orbitopathy].Composition, Architecture, and Functional Implications of the Connective Tissue Network of the Extraocular Muscles.Radiographic evidence of prominent retro and suborbicularis oculi fat in thyroid-associated orbitopathy.Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
P2860
Q21285043-0287FD41-2393-487D-92BA-3E25FBE8EC8FQ24202845-3193226B-D5EE-4D53-B868-FE53FD5E67D3Q24235160-5952456A-0B62-4245-AD9A-2B68A88567EBQ33574320-B0073FCF-4494-4820-9CAB-C92943ADE634Q34275875-6C8E2DCC-ADB1-44B3-A148-32ED4001F24FQ34997058-607C0F3A-60DA-4E8A-8738-544963351F88Q35012933-564ABD7A-CE60-426E-B6F0-5869768CFF14Q35607571-7F8359EA-8743-4039-97E7-189EB4655A10Q35922627-C8847865-AE3E-4045-9969-E48D2091785CQ36024573-1A899E81-1B2A-43E4-BF2F-B5DF19C05CCCQ36070800-7219C66C-F629-40E1-817B-9CB7821BAF43Q36872831-3D538AC2-B1DC-4A23-9319-8F26DE0D94F3Q37670358-575B1B7D-88B5-4396-8E69-800CDBD9073AQ37722271-2A689A8F-C215-42DE-BA74-D87C12037BE9Q38012510-6A1F52D9-44D8-4B41-A2DA-496DEF83878BQ38293593-E70D1658-9FBC-4E4B-8416-04FBC7DD4BC1Q40962257-06936953-6220-4A84-A4BB-6B5149E804D1Q48913225-BD5CE589-9013-49F7-A3C6-CCE3C8C33C73Q49213300-D2E0C1AD-31C1-4864-B185-26D9437AA5D1Q50948749-A7D85FDA-264E-4F13-AEA1-1F0E16F69DC8Q51612155-3E019E7D-5CFD-4C7A-B5BE-5422059F1D4EQ54177827-CAF8EEDA-EAD8-41E7-9D45-DB40B0B6B8D1
P2860
Current insights into the pathogenesis of Graves' orbitopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current insights into the pathogenesis of Graves' orbitopathy.
@en
Current insights into the pathogenesis of Graves' orbitopathy.
@nl
type
label
Current insights into the pathogenesis of Graves' orbitopathy.
@en
Current insights into the pathogenesis of Graves' orbitopathy.
@nl
prefLabel
Current insights into the pathogenesis of Graves' orbitopathy.
@en
Current insights into the pathogenesis of Graves' orbitopathy.
@nl
P2093
P356
P1476
Current insights into the pathogenesis of Graves' orbitopathy.
@en
P2093
P304
P356
10.1055/S-0029-1220935
P577
2009-06-01T00:00:00Z